Chronic Pain

Acute pain is the body's normal alarm system — a short-lived warning that something is wrong, such as a burn, cut, or fracture, which usually fades as the injury heals. Pain that continues for longer than about three months is called chronic pain, and it is one of the most common reasons adults seek medical care. A U.S. study found that roughly one in five adults lives with chronic pain, making it a major public-health problem. The defining feature is duration: chronic pain may linger long after an injury has healed, accompany an ongoing condition such as arthritis, or appear without any clear injury at all. Crucially, chronic pain is increasingly understood not just as a symptom but as a health condition in its own right, because the nervous system itself can change in ways that keep pain switched on. That shift in thinking matters, because it explains why 'find the damage and fix it' often does not work for long-standing pain and why management focuses on improving function and quality of life.

Modern pain science views pain through a biopsychosocial lens: the experience of pain emerges from the interaction of biological factors (nerves, tissues, inflammation, nervous-system sensitivity), psychological factors (mood, stress, fear, attention, beliefs about pain), and social factors (relationships, work, sleep, finances, past experiences). This is not a claim that pain is 'imaginable' or 'not real' — pain is always real — but a recognition that the same injury can hurt very differently in different people and circumstances because the brain constructs the experience from many inputs. The model explains common observations: why anxiety and poor sleep amplify pain, why low mood and isolation make it harder to cope, and why two people with identical scans can have very different pain. It is also the foundation of effective treatment, because it points to multiple levers — physical, psychological, and social — rather than a single pill or procedure. Care that ignores the psychological and social dimensions tends to underperform, which is why pain specialists work across all three.

The International Association for the Study of Pain (IASP) describes three broad mechanisms that help make sense of chronic pain. Nociceptive pain arises from actual or threatened damage to non-nerve tissue and a normally functioning nervous system — for example arthritis, a sprain, or post-surgical pain; it often feels aching or throbbing. Neuropathic pain is caused by a lesion or disease of the nerves themselves (the somatosensory nervous system) — examples include diabetic nerve pain, sciatica, and post-shingles pain — and tends to feel burning, shooting, or electric, sometimes with numbness. Nociplastic pain, a term IASP adopted in 2017, arises from altered processing of pain signals despite no clear tissue or nerve damage; fibromyalgia is the classic example. These categories are not mutually exclusive — many people have 'mixed' pain with more than one mechanism — but they matter because treatment differs: for instance, anti-inflammatory drugs target nociceptive pain, certain antidepressants and anti-seizure drugs target neuropathic and nociplastic pain, and the nervous-system-focused approaches matter most for nociplastic pain.

The World Health Organization's ICD-11 disease classification formally recognizes chronic pain and divides it into two groups. Chronic primary pain is pain that is best understood as a health condition in its own right — it cannot be fully explained by another diagnosis and is associated with significant distress or disability; fibromyalgia, chronic primary low back pain, and chronic primary headache fall here. Chronic secondary pain is pain that occurs as a symptom of an underlying condition, such as chronic cancer-related pain, pain from osteoarthritis, post-surgical or post-traumatic pain, and chronic neuropathic pain. The distinction is practical: for secondary pain, treating the underlying disease may help the pain, whereas for primary pain, the pain itself is the target of treatment. Either way, modern care recognizes that long-standing pain involves changes in the nervous system, so management often blends approaches aimed at the body, the nerves, and the brain's pain-processing systems rather than searching endlessly for a single fixable cause.

Chronic pain is the main symptom of a wide range of injuries, infections, and diseases, so it appears in many guises. Among the most common are chronic low back pain (one of the leading causes of disability worldwide), osteoarthritis and other joint pain, neck pain, and widespread pain conditions like fibromyalgia. Neuropathic conditions — diabetic peripheral neuropathy, sciatica, post-herpetic neuralgia after shingles, and complex regional pain syndrome — form another large group. Headache disorders, especially migraine and chronic tension-type headache, are extremely common, as is chronic pelvic pain, cancer-related pain, and pain from autoimmune and inflammatory diseases. Many people have more than one painful condition at once. Because the conditions differ so much in cause and in which treatments help, accurate description of the pain — where it is, what it feels like, what makes it better or worse, and how it affects daily life — is an important first step. The shared thread across all of them is persistence beyond three months and an impact on function and wellbeing that the care plan aims to address.

Normally, specialized nerve endings called nociceptors detect potentially harmful stimuli — heat, pressure, chemicals from injury — and send electrical signals through peripheral nerves to the spinal cord, where they are relayed up to the brain. The brain then integrates these signals with context, memory, and emotion and produces the experience of pain, which motivates us to protect the injured area while it heals. This is a protective, adaptive system: acute pain is useful. In most cases, as tissue heals the signals quiet and the pain resolves. Chronic pain represents a breakdown of this normal arc — the alarm keeps sounding after the danger has passed, or the system becomes oversensitive so that ordinary signals are amplified into pain. Understanding that the brain actively produces pain (rather than passively receiving it from the body) helps explain why pain can persist without ongoing damage and why treatments aimed at the nervous system and the brain — not just the tissues — can help.

A central puzzle of chronic pain is why, in some people, pain persists long after the original injury has healed. Research points to changes along the whole pain system: peripheral nerves and the spinal cord can become more excitable, and the brain's pain-processing and emotional circuits can reorganize so that pain becomes self-sustaining — a kind of learned response. Many factors influence whether this transition happens, including the severity and type of the initial injury, genetics, and powerful psychosocial contributors such as depression, anxiety, high stress, poor sleep, fear of movement, and certain beliefs about pain. This is why the same surgery or injury leaves one person pain-free and another with lasting pain. The practical importance is twofold: it underlines that long-standing pain is a real, biologically grounded process (not 'all in the head'), and it identifies modifiable factors — sleep, mood, activity, stress — that can be addressed to reduce the risk of pain becoming entrenched or to help unwind it once it has.

Nociceptive pain is the most familiar kind: it arises from activation of nociceptors by actual or threatened damage to non-nerve tissue, with a normally functioning nervous system. Inflammation, mechanical stress, and chemical irritants in the tissues drive it. Chronic examples include osteoarthritis, rheumatoid and other inflammatory arthritis, chronic back and neck pain from joints and muscles, and pain from ongoing tissue conditions. It is often described as aching, throbbing, gnawing, or sharp, and it usually localizes to the affected area. Because the problem is rooted in tissues and inflammation, nociceptive pain tends to respond, at least in part, to treatments that target those processes — anti-inflammatory medicines, physical therapy, weight management for load-bearing joints, and sometimes injections or surgery for a specific structural cause. Many chronic pain conditions, however, are 'mixed,' combining a nociceptive driver with neuropathic or nociplastic features, which is why careful assessment of what the pain feels like and how it behaves guides treatment.

Neuropathic pain results from a lesion or disease of the somatosensory nervous system — the nerves, spinal cord, or brain pathways that carry sensation — rather than from tissue injury. Damaged nerves can fire abnormally and spontaneously, and the system can amplify or distort signals, producing characteristic sensations: burning, shooting, stabbing, or electric-shock pain, often with tingling, pins-and-needles, numbness, or a heightened, painful response to light touch (allodynia). Common causes include diabetic peripheral neuropathy, nerve compression such as sciatica, post-herpetic neuralgia after shingles, nerve injury from trauma or surgery, multiple sclerosis, and stroke (central pain). Because the mechanism is different from tissue pain, ordinary painkillers and anti-inflammatories often help little; instead, certain antidepressants (such as duloxetine and tricyclics) and anti-seizure medicines (gabapentin, pregabalin) are first-line because they calm overactive nerve signaling. Recognizing neuropathic features matters precisely because it changes which treatments are likely to work.

Nociplastic pain arises from altered processing of pain in the nervous system despite no clear evidence of tissue damage or nerve injury. A key underlying process is central sensitization: neurons in the spinal cord and brain become hyperexcitable, so the pain system's 'volume' is turned up. The result is pain that is amplified, more widespread than any single injury would explain, and often accompanied by heightened sensitivity to touch, sound, light, or temperature, along with fatigue, poor sleep, and difficulty concentrating. Fibromyalgia is the prototypical nociplastic pain condition, and central sensitization is also thought to contribute to conditions such as irritable bowel syndrome, chronic tension headache, and some long-standing back pain. Importantly, this pain is entirely real even though scans and blood tests are typically normal — the problem is in pain processing, not a visible lesion. Because the driver is the nervous system rather than the tissues, management leans on exercise, sleep, stress reduction, pain psychology, and medicines that act on nerve signaling rather than anti-inflammatories or surgery.

Psychological and social factors are not separate from pain biology — they act directly on the nervous system that produces pain. Stress, anxiety, fear of movement, low mood, and poor sleep all turn up pain sensitivity and reduce the body's natural pain-dampening systems, while attention to pain and catastrophic thinking ('this will never get better') can intensify and prolong it. The relationship is two-way: pain disturbs sleep and mood, and disturbed sleep and mood worsen pain, creating self-reinforcing cycles. Social context matters too — work stress, isolation, financial strain, and past trauma all influence how much pain a person experiences and how well they cope. None of this means the pain is 'in your head' or not real; it means the brain and body are one system, and the psychological and social inputs are genuine biological levers. This is the rationale for treatments like cognitive behavioral therapy, sleep improvement, stress reduction, and graded return to activity, which work by changing the same circuits that generate pain.

Unlike blood pressure or blood sugar, pain cannot be measured by any laboratory test or scan — it is a subjective experience known only to the person feeling it. This is a defining challenge of pain care: the most reliable information is the person's own description of their pain. A good assessment therefore centers on a careful history (where the pain is, what it feels like, when it started, what makes it better or worse, how it changes through the day) and its impact on sleep, mood, work, and daily activities, combined with a physical examination and, when needed, targeted tests. Investigations such as blood tests or imaging are used not to 'see' the pain but to look for treatable underlying causes and to rule out serious conditions. Because the person's report is central, being believed and taken seriously is itself part of good care — and dismissing pain because tests are normal is a known pitfall, since many real pain conditions, including neuropathic and nociplastic pain, leave no visible mark on standard tests.

Assessment usually begins with a detailed pain history. Clinicians ask about the site and spread of pain, its character (aching, burning, shooting, throbbing), severity, timing and pattern, what aggravates and eases it, associated symptoms (numbness, weakness, stiffness), and — importantly — how it affects sleep, mood, relationships, work, and the activities the person values. Past treatments and their effects, other medical conditions, and current medications (including any opioids, sedatives, and supplements) are reviewed. A focused physical examination follows, checking the painful area, range of movement, strength, reflexes, and sensation, and looking for signs that point to a specific cause or to neuropathic features. The goal is not only to label the pain but to understand its mechanism and its effect on the person's life, since both shape the plan. This thorough, person-centered evaluation often reveals more than any scan, and it is the basis for the shared, realistic goals that effective chronic-pain care is built around.

Because pain cannot be measured directly, clinicians use rating tools to capture and track it. The simplest is a numeric rating scale (0 = no pain, 10 = worst imaginable pain); visual analog scales and faces scales serve similar purposes, and the latter help children or people who find numbers hard. More detailed questionnaires assess the quality of pain, its interference with daily life, and features suggesting neuropathic pain. Increasingly, the emphasis is on function and quality of life rather than the pain score alone: how well a person sleeps, moves, works, and does what matters to them is often a better guide to whether treatment is helping, since a realistic goal in chronic pain is usually a meaningful reduction in suffering and improvement in function rather than zero pain. Tracking these measures over time — sometimes in a pain diary — helps the person and care team see patterns, evaluate treatments honestly, and adjust the plan. The numbers are tools for conversation and tracking, not a competition or a test to pass.

A key job of assessment is to characterize the pain mechanism, because nociceptive, neuropathic, and nociplastic pain respond to different treatments. Burning, shooting, electric, or tingling pain with numbness suggests a neuropathic component, and screening questionnaires plus the exam help identify it. Aching, throbbing pain tied to a joint, muscle, or inflamed tissue suggests nociceptive pain. Widespread pain with heightened sensitivity, fatigue, poor sleep, and normal tests suggests nociplastic pain such as fibromyalgia. In practice, many people have 'mixed' pain — for example chronic low back pain can combine nociceptive, neuropathic, and nociplastic elements — so clinicians weigh the dominant features rather than forcing a single label. Getting this right matters: anti-inflammatories help inflammatory nociceptive pain but little for neuropathic or nociplastic pain, whereas drugs like duloxetine, gabapentin, or pregabalin and nervous-system-focused therapies are central for the latter. Matching treatment to mechanism is one of the most useful things a careful assessment delivers.

It is natural to want a scan to 'find the cause' of chronic pain, but imaging frequently misleads. Studies show that findings often labeled abnormal — disc bulges, degeneration, arthritis changes — are extremely common in people with no pain at all, and their prevalence rises with age. As a result, a scan may reveal something that is not actually the source of the pain, leading to unnecessary worry, more tests, or even procedures that do not help. For these reasons, guidelines generally advise against routine imaging for common low back pain and similar conditions in the absence of red-flag features (such as signs of serious nerve compression, infection, fracture, or cancer). Imaging has an important role when the history and exam raise specific concerns or when results would change management. Understanding this helps explain why a clinician may not order a scan even when pain is severe — not because the pain is doubted, but because the scan is unlikely to help and can sometimes cause harm. Decisions about imaging belong with the care team based on the individual picture.

Because chronic pain so often coexists with depression, anxiety, and sleep disturbance — each of which worsens pain and is treatable — comprehensive assessment screens for these and for the impact of pain on mental health. Identifying and addressing them is part of effective pain care, not an add-on. Assessment also weighs the safety of treatments. The CDC's clinical practice guideline emphasizes that before starting or continuing opioids, clinicians should evaluate the balance of benefits and risks for the individual, discuss realistic goals, and assess factors that raise the risk of harm — such as a history of substance use disorder, mental health conditions, sleep apnea, older age, and concurrent use of benzodiazepines or other sedatives. Strategies like checking prescription drug monitoring programs, offering naloxone to those at higher overdose risk, and arranging follow-up are recommended. This is not about denying treatment but about tailoring it safely. All of these assessments feed into a shared, individualized plan made with the care team, never a one-size-fits-all rule.

Anyone taking prescription opioids — and those around them — should know the signs of an opioid overdose, because it is a leading cause of preventable death. In an overdose, opioids suppress the brain's drive to breathe. The classic signs are very small, 'pinpoint' pupils; unresponsiveness or inability to wake the person; and slow, shallow, irregular, or stopped breathing, sometimes with gurgling or snoring-like (gasping) sounds. The skin may turn pale, bluish, or gray, especially the lips and fingertips, and the body may go limp. An overdose is a medical emergency: call 911 (or local emergency services) immediately, give naloxone if it is available, try to keep the person breathing, and stay with them. Overdose risk is higher with higher opioid doses, after a period of reduced tolerance (such as following detox, hospitalization, or a missed-then-doubled dose), and — critically — when opioids are combined with other substances that slow breathing, such as benzodiazepines, alcohol, or sleep medicines.

Naloxone is a medicine that can rapidly reverse an opioid overdose by knocking opioids off their receptors and restoring breathing. It comes as an easy-to-use nasal spray (generic naloxone, Narcan, Kloxxado) and as an injection; the nasal spray is designed for bystanders without medical training and, in the U.S., is available over the counter. Public-health bodies recommend that people prescribed opioids — and their family members or housemates — keep naloxone available and know how to use it, much like keeping a fire extinguisher. Important points: naloxone only works on opioids, it is safe to give even if you are not certain opioids are involved, and it wears off in roughly 30–90 minutes — which can be shorter than the opioid's effect, so a person can slip back into overdose. For that reason you must always call 911, give a second dose if breathing does not improve, and keep the person under observation until help arrives. Naloxone does not replace emergency care; it buys time. Ask a pharmacist or clinician how to obtain and use it.

One of the most important safety messages in chronic pain care is that opioids combined with other substances that depress the central nervous system are far more dangerous than opioids alone. Benzodiazepines (such as diazepam, alprazolam, lorazepam — often prescribed for anxiety or sleep), alcohol, the 'Z-drug' sleep medicines, gabapentinoids at high doses, muscle relaxants, and sedating antihistamines all slow breathing, and their effects stack with opioids to cause profound respiratory depression. The combination of opioids and benzodiazepines in particular is involved in a large share of opioid-overdose deaths, which is why the CDC guideline advises clinicians to avoid prescribing them together whenever possible. This does not mean a person currently taking both has done something wrong, but it is a high-risk situation that should be reviewed with the prescriber and pharmacist — never altered abruptly on one's own, since stopping some of these drugs suddenly is itself dangerous. Anyone taking opioids should tell every clinician about all sedatives, sleep aids, and alcohol use so the combined risk can be managed and naloxone offered.

Cauda equina syndrome is a rare but serious emergency in which the bundle of nerves at the base of the spinal cord is compressed, and it must be recognized fast because delay can cause permanent loss of bladder, bowel, and sexual function and leg weakness. Warning signs, often appearing alongside back or leg pain, include: difficulty passing urine or new loss of bladder or bowel control (incontinence or retention); numbness or altered sensation around the genitals, buttocks, or inner thighs and the area that would contact a saddle ('saddle anesthesia'), sometimes noticed when wiping after using the toilet; numbness or weakness in one or both legs; and reduced sexual sensation. If two or more of these develop or change rapidly, this is a medical emergency — go to the emergency department (A&E) right away rather than waiting for a routine appointment, because early surgery to relieve the pressure offers the best chance of avoiding lasting damage. People living with chronic back pain should know these specific red flags so they can act quickly if the picture suddenly changes.

Most back pain is not dangerous, but certain features ('red flags') suggest a serious underlying cause and warrant prompt medical assessment rather than watchful waiting. These include: pain following significant trauma (such as a fall or crash), which can mean fracture; fever, chills, or a recent infection or injection, which can signal a spinal infection; a history of cancer, unexplained weight loss, or night pain that wakes the person, which can indicate cancer spreading to the spine; progressive or severe weakness, numbness, or pins-and-needles in the legs, which can signal serious nerve compression; pain in someone with osteoporosis or on long-term steroids, which raises fracture risk; and being very young or older when back pain first appears. New problems with walking, balance, or coordination are also concerning. These features do not by themselves mean something serious is present, but they change the urgency, so the person should contact a clinician promptly (or seek emergency care for severe or rapidly worsening symptoms). Knowing the red flags helps distinguish the common, non-dangerous back pain from the rare situations that need quick action.

Living with chronic pain can make it tempting to attribute every new symptom to the existing condition, but some changes warrant urgent evaluation. Seek emergency care for sudden, severe, or 'worst-ever' pain; chest pain or pain spreading to the arm, jaw, or back with breathlessness, sweating, or nausea (possible heart attack); the 'thunderclap' worst-ever headache (possible bleeding in the brain); a sudden severe headache with stiff neck, fever, confusion, or rash; signs of infection such as fever with a hot, swollen, red joint or area; new weakness, numbness, difficulty speaking, or facial drooping (possible stroke); or signs of an opioid overdose. More generally, a marked, unexplained change in a familiar pain pattern, new neurological symptoms, or pain accompanied by systemic features (fever, weight loss, night sweats) should prompt contact with a clinician rather than being dismissed. The guiding principle is that chronic pain does not make a person immune to new, acute problems — and when in doubt about a sudden or severe change, it is safer to seek urgent advice or emergency care.

A core principle of chronic-pain treatment is to be multimodal: to combine several approaches — different classes of medicine plus non-drug therapies — rather than leaning on any one. There are two reasons. First, no single medication reliably abolishes chronic pain; on average, people get only partial relief from any one treatment, so combining approaches that work in different ways tends to help more than escalating a single drug. Second, using several treatments at lower intensity can reduce the side effects and risks of pushing any one (especially opioids) to high doses. The choice of medicines is matched to the pain mechanism — anti-inflammatories for inflammatory nociceptive pain, nerve-targeting drugs for neuropathic and nociplastic pain — and combined with physical therapy, exercise, and psychological approaches. Realistic goals matter: success is usually meaningful improvement in pain and, crucially, function and quality of life, not a pain score of zero. The specific combination is individualized by the care team, weighing what works, side effects, other conditions, and the person's goals.

Non-opioid analgesics are often the first medicines tried for many kinds of pain. Acetaminophen (paracetamol) reduces pain and fever and is generally well tolerated, but exceeding the recommended daily amount — easy to do because it is hidden in many combination products — can cause serious liver damage, and the margin is narrower for people with liver disease or significant alcohol use. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, and diclofenac reduce inflammation as well as pain, making them useful for arthritis and other inflammatory nociceptive pain, but they carry risks including stomach ulcers and bleeding, kidney injury, raised blood pressure, fluid retention, and cardiovascular effects — risks that rise with higher doses, longer use, older age, and certain conditions. For neuropathic and nociplastic pain these drugs often help little. Because of these trade-offs, even 'over-the-counter' painkillers should be used at the lowest effective dose for the shortest time needed, and anyone with kidney, heart, liver, or stomach conditions, or taking other medicines, should check suitability with a pharmacist or clinician.

Neuropathic pain (from nerve damage) and nociplastic pain (from altered central processing, as in fibromyalgia) usually respond poorly to ordinary painkillers, so different medicines are used that quiet overactive or oversensitive nerve signaling. First-line options commonly include certain antidepressants — duloxetine (an SNRI) and tricyclics such as amitriptyline and nortriptyline — and the anti-seizure 'gabapentinoids' gabapentin and pregabalin. These are not being used to treat depression or epilepsy here; they work on pain pathways directly, which is why they help even in people who are not depressed. They are typically started low and increased gradually, can take days to weeks to show benefit, and have side effects (drowsiness, dizziness, dry mouth, weight changes, and others) that influence the choice. Gabapentinoids in particular can add to the sedating, breathing-slowing effects of opioids and other depressants, an interaction the prescriber weighs carefully. As with all pain medicines, the right agent, dose, and combination are individualized by the care team, and benefits are judged against side effects and effect on function.

Topical treatments are applied to the skin over a painful area and can provide relief with lower levels of drug reaching the rest of the body, which often means fewer systemic side effects. Topical NSAID gels (for example diclofenac gel) can help localized nociceptive pain such as knee or hand osteoarthritis and are sometimes preferred over oral NSAIDs in older adults or those with stomach, kidney, or heart concerns. For localized neuropathic pain, lidocaine patches or gels (which numb the area) and capsaicin (derived from chili peppers, which works by depleting a pain-signaling chemical) are options; capsaicin can cause burning when first applied. Counter-irritant rubs containing menthol or similar ingredients are widely sold for temporary relief. Topicals are not free of effects — they can still be absorbed, cause skin reactions, or interact, and they are not suitable on broken skin — so they remain part of a plan guided by the care team. Their appeal is targeted relief, and they fit naturally into a multimodal approach alongside oral medicines and non-drug therapies.

Opioids (such as morphine, oxycodone, hydrocodone, tramadol, fentanyl, and buprenorphine) are powerful pain relievers with an important role in certain situations — acute severe pain, cancer pain, and end-of-life care — but for most chronic non-cancer pain they are not first-line. The CDC's 2022 guideline emphasizes maximizing non-opioid and non-drug treatments first, and, when opioids are considered, starting at the lowest effective dose, setting realistic goals, and regularly weighing benefits against harms. The reasons for caution are substantial: over time the body develops tolerance (needing more for the same effect) and physical dependence (withdrawal if stopped abruptly), and a minority develop opioid use disorder; opioids also cause constipation, drowsiness, hormonal effects, and — most dangerously — slowed breathing that can be fatal in overdose, a risk that rises sharply with higher doses and with other sedatives. For many people the long-term pain benefit is modest while the risks accumulate. None of this means opioids are never appropriate, but it explains why they are used selectively, monitored closely, paired with naloxone for those at risk, and reviewed regularly — all decisions made with the prescriber.

Sometimes opioids are reduced or stopped — because benefits are limited, side effects or risks outweigh gains, or the person wishes to come off them. How this is done matters a great deal. The body adapts to regular opioids, so stopping suddenly can cause a very unpleasant withdrawal syndrome (aches, sweating, nausea, agitation, insomnia) and, importantly, can be unsafe: rapid or forced tapering has been linked to worse pain, distress, and even crises including overdose if a person seeks relief elsewhere. For these reasons, guidance from the CDC and others stresses that any taper should generally be slow, individualized, voluntary where possible, and supported — with the pace adjusted to how the person responds, attention to mood and function, and treatment of withdrawal symptoms. Other parts of the pain plan (non-opioid medicines, physical and psychological therapies) are strengthened alongside. The key educational points are that tapering is a collaborative process planned with the prescriber, that it is not a punishment, and that nobody should abruptly stop prescribed opioids on their own. Anyone struggling with opioids — including signs of dependence or use disorder — should be offered help, not abandoned.

When pain comes from an identifiable structure, interventional procedures can sometimes provide relief, typically as one part of a multimodal plan. Common examples include epidural steroid injections for nerve-root pain such as sciatica; joint and bursa injections of steroid and local anesthetic for arthritis-related pain; nerve blocks that interrupt a specific nerve's signals; trigger-point injections for certain muscle pain; and radiofrequency ablation, which uses heat to disable a small nerve carrying pain signals (often used for some spinal facet-joint pain). Benefits vary widely between conditions and individuals — some procedures offer temporary relief that allows progress with rehabilitation, while evidence for lasting benefit is mixed for several indications. Procedures carry their own small risks (bleeding, infection, nerve irritation, and effects of steroids) and are generally chosen when the pain source is reasonably clear and conservative measures have not been enough. They work best when paired with physical therapy and the rest of the plan rather than treated as a one-time fix. Whether a procedure is appropriate is a decision for a pain specialist based on the individual's diagnosis.

Neuromodulation treats pain by delivering electrical signals that change how pain is transmitted or perceived. At the simplest level, transcutaneous electrical nerve stimulation (TENS) applies a mild current through pads on the skin; it is low-risk and helps some people, though the evidence for lasting benefit is modest and mixed. More advanced is spinal cord stimulation, in which a small device is implanted to send electrical pulses to the spinal cord; it is used for selected people with certain chronic pain conditions — such as persistent pain after back surgery or some neuropathic pain syndromes — usually after a trial period to gauge whether it helps before permanent implantation. Related techniques target peripheral nerves or other sites. These approaches do not cure the underlying problem; they aim to reduce pain enough to improve function, and they are reserved for carefully selected patients after other treatments, given the cost, the surgery involved, and variable results. As with interventional procedures, suitability is determined by a specialist, and neuromodulation fits within — rather than replacing — a comprehensive pain plan.

Exercise and movement are cornerstones of chronic-pain management and among the most consistently supported approaches across many pain conditions. This runs counter to the natural instinct to rest, but prolonged rest tends to make most chronic pain worse over time — muscles weaken, joints stiffen, fitness declines, mood drops, and the nervous system can become more sensitive. Appropriate activity does the opposite: it strengthens and conditions the body, improves mood and sleep, and can actually turn down pain sensitivity. The key is a gradual, individualized approach rather than overdoing it, often starting gently and building up. Many kinds of activity help — walking, swimming, cycling, strengthening, stretching, and movement practices like yoga or tai chi — and the 'best' exercise is largely the one a person will stick with and enjoy. A brief flare after starting new activity is common and usually not harmful. A physical therapist or care team can tailor a program to the person's condition and goals, which makes it safer and more effective than going it alone.

Physical therapy (physiotherapy) is a frontline, non-drug treatment for many chronic-pain conditions. Rather than passive treatments alone, modern physical therapy emphasizes active rehabilitation: an individualized program of stretching, strengthening, aerobic conditioning, and movement retraining, often combined with education about pain and how to move with confidence. A particularly important principle is graded activity (or graded exposure) — gradually and systematically increasing activity in manageable steps, working to a plan rather than to pain, so the body and nervous system adapt and the person rebuilds capacity without repeated boom-and-bust flares. Therapists also address fear of movement, which commonly develops with persistent pain and can lead to avoidance that worsens disability. Hands-on techniques, posture and ergonomic advice, and aids may complement the active work. Because programs are tailored to the diagnosis, goals, and starting fitness, a physical therapist can make activity safer and more effective. The overall aim is function — getting back to valued activities — with pain reduction often following improved movement.

A common pattern in chronic pain is 'boom and bust': on better days a person does a great deal, triggers a flare, then rests for days to recover, and the cycle repeats — leaving overall activity low and unpredictable. Pacing is a self-management skill that breaks this cycle by spreading activity more evenly. In practice it means planning and prioritizing tasks, breaking big jobs into smaller chunks with rest or change-of-task built in, alternating demanding and lighter activities, and gradually increasing activity in a steady, sustainable way rather than reacting to how the pain feels moment to moment. Done well, pacing helps people do more reliably and with fewer big flares, and it works hand in hand with graded activity from physical therapy. It is not about doing less for its own sake; it is about doing things in a smarter, more consistent pattern so that progress accumulates. Many people learn pacing through pain-management programs, physical or occupational therapists, or pain psychology, and it is a skill that improves with practice.

Sleep and pain have a strong two-way relationship. Pain makes it harder to fall and stay asleep, and poor or insufficient sleep in turn lowers the pain threshold and worsens pain the next day, along with mood, concentration, and the ability to cope — a cycle that can entrench both problems. Because of this, improving sleep is a genuine pain-management strategy, not just a comfort measure. Helpful approaches focus first on sleep habits ('sleep hygiene'): a consistent sleep and wake time, a wind-down routine, a cool dark quiet bedroom, limiting screens, caffeine, alcohol, and large meals near bedtime, and getting daytime activity and light. For persistent insomnia, cognitive behavioral therapy for insomnia (CBT-I) is an effective, non-drug treatment. Treating sleep disorders that often accompany pain, such as obstructive sleep apnea, also matters. Some pain medicines affect sleep (and some sleep medicines interact dangerously with opioids), so changes are coordinated with the care team. Prioritizing sleep frequently improves not only rest but the pain itself.

General health habits influence chronic pain in several ways. For weight-bearing joint pain such as knee and hip osteoarthritis and some back pain, carrying excess weight increases mechanical load and is associated with more pain, so for people who are overweight, gradual weight loss can meaningfully reduce joint pain and improve function — often best achieved by combining dietary change with the exercise that is already central to pain care. Beyond joint loading, excess body fat is linked to low-grade inflammation that may influence pain more broadly. There is no single proven 'pain diet,' but an overall healthy eating pattern — plenty of vegetables, fruits, whole grains, and healthy fats, with less ultra-processed food, added sugar, and excess alcohol — supports general health, mood, sleep, and the conditions that often accompany pain (such as diabetes and heart disease). Some people explore anti-inflammatory eating patterns; evidence for specific diets in pain is limited and mixed. Nutrition is best seen as a supportive part of the bigger plan rather than a stand-alone treatment, and significant dietary changes are worth discussing with the care team, especially alongside other conditions.

One of the most misunderstood parts of pain care is the role of psychology. Because pain is produced by the brain and shaped by attention, emotion, stress, and beliefs, treatments that change these factors act directly on the systems that generate pain — which is why they can reduce both pain and its impact. This is a biological effect, not a suggestion that the pain is fake or 'all in the head': the pain is entirely real, and psychological therapy is a legitimate, mainstream treatment for it, much as physical therapy treats the body. These approaches help people respond to pain in ways that reduce suffering and disability — turning down the stress and fear that amplify pain, breaking unhelpful cycles, restoring activity and sleep, and improving mood. They are often most powerful as part of a multidisciplinary plan alongside exercise and medical treatment. Referral to a pain psychologist or a pain-management program is a sign of comprehensive care, not a hint that a clinician thinks the pain is imagined.

Cognitive behavioral therapy is among the best-studied psychological treatments for chronic pain. It is a practical, skills-based therapy that helps people notice and change unhelpful thought patterns (such as catastrophizing — 'this pain means something terrible and will never improve') and behaviors (such as avoiding activity out of fear), which can otherwise amplify pain and disability. Through CBT, people learn coping strategies: pacing activity, relaxation, problem-solving, challenging fearful thoughts, improving sleep, and gradually returning to valued activities. The goal is not to talk the pain away but to reduce its grip on daily life and lower the distress that feeds it. Reviews find CBT can produce modest but meaningful improvements in pain, mood, and function that often persist after therapy ends, and it is recommended across many pain conditions. It is typically delivered over a series of sessions by a trained therapist, individually or in groups, and increasingly through digital programs. CBT works best as part of a broader, active pain-management plan rather than in isolation.

Acceptance and commitment therapy is a form of cognitive behavioral therapy increasingly used for chronic pain, with a distinctive emphasis. Rather than focusing mainly on reducing or controlling pain, ACT helps people change their relationship to pain — accepting the presence of difficult sensations and feelings without being ruled by them, and committing energy to the activities and goals that matter to them ('values-based living'). Core skills include mindfulness, 'defusion' (stepping back from unhelpful thoughts so they hold less power), and identifying what one wants life to be about despite pain. The rationale is that fighting hard against pain, or putting life on hold until it disappears, can deepen suffering and shrink a person's world; ACT aims to expand life again. Evidence supports ACT for improving function, mood, and quality of life in chronic pain, with effects comparable to traditional CBT for many outcomes. Like CBT, it is delivered by trained therapists and works as part of a comprehensive plan; it is especially helpful when complete pain relief is not realistic and the goal is living well alongside persistent pain.

Mindfulness-based approaches, including mindfulness-based stress reduction (MBSR) and mindfulness meditation, teach people to pay attention to the present moment — including pain sensations — with openness and without judgment, rather than reacting with fear or resistance. This can change how the brain processes pain and reduce the stress and emotional reactivity that amplify it. NCCIH-reviewed research indicates that mindfulness meditation programs can modestly reduce chronic-pain intensity and improve depression symptoms and quality of life for some people, and that the practice is generally safe. It is used across conditions including chronic low back pain, fibromyalgia, and headache, often within structured 8-week programs and increasingly via apps and online courses. Mindfulness is a skill that builds with regular practice, and benefits tend to grow with consistency. It is not a cure and works best alongside exercise, medical treatment, and other psychological tools, but it is a low-risk, accessible option that gives many people a greater sense of control over their pain experience.

Relaxation training and biofeedback target the physical stress response that often accompanies and amplifies chronic pain. Relaxation techniques — such as deep diaphragmatic breathing, progressive muscle relaxation, and guided imagery — help calm the nervous system, ease muscle tension, and reduce the anxiety that feeds pain; they are simple, low-risk, and can be practiced anywhere once learned. Biofeedback adds electronic sensors that show real-time information about body functions like muscle tension, heart rate, or skin temperature, helping a person learn to consciously influence them — for example, relaxing tense muscles or slowing their breathing. NCCIH notes that relaxation and biofeedback have evidence for certain conditions, particularly tension-type headache and migraine, and they can be useful components of a broader plan for other pain too. These methods give people an active coping skill and a sense of agency over their body's responses. They are usually taught by a therapist or through structured programs and, like other mind-body tools, work best with regular practice and as part of multimodal care.

A growing part of modern pain care is helping people understand how pain really works, sometimes called pain-neuroscience education. The central messages are that pain is produced by the brain as a protective output, that 'hurt does not always equal harm' (especially in persistent pain where tissues have healed), and that the nervous system can become oversensitized so that it amplifies signals. Understanding this can be therapeutic in itself: it reduces the fear, catastrophizing, and avoidance that worsen pain and disability, and it makes the rationale for active treatments — gradually resuming movement, pacing, addressing sleep and stress — make sense, which improves engagement and outcomes. This education does not replace other treatments; it sets the stage for them by reframing pain from a sign of ongoing damage to be feared into a changeable, modifiable experience that a person can influence. It is delivered by clinicians, physical therapists, psychologists, and pain programs, and reputable patient resources reinforce the same ideas. Knowing that the pain system can be retrained gives many people both reassurance and a reason for hope.

For many people, chronic pain cannot be made to disappear, and chasing a pain score of zero can lead to frustration, escalating treatments, and disappointment. Modern pain care therefore reframes success around function and quality of life: being able to sleep better, walk further, return to work or hobbies, play with grandchildren, or simply do more of what matters. These goals are concrete, measurable, and motivating, and pursuing them often reduces pain as a by-product because activity, mood, and sleep all improve. Setting goals collaboratively with the care team — specific, realistic, and personally meaningful — gives direction to the plan and a fairer way to judge whether treatments are helping than the pain number alone. It also shifts the focus from a passive search for a cure to an active process the person leads. Accepting that the aim is to live well alongside pain, rather than to eliminate it, is not giving up; for most people it is the path that actually improves both pain and life.

Chronic pain is managed day to day mostly by the person living with it, so self-management skills are central to good outcomes. These include understanding the condition, using pacing and graded activity, practicing relaxation or mindfulness, keeping up exercise and sleep routines, taking medicines as agreed, and knowing how to handle flares. Many people benefit from tracking — a simple diary or app noting pain levels, activity, sleep, mood, triggers, and what helps — which reveals patterns, supports better conversations with clinicians, and shows progress that day-to-day fluctuations can hide. Structured self-management or pain-education programs, sometimes led by peers, teach these skills and consistently improve confidence and coping. The shift from being a passive recipient of treatment to an active, informed partner is itself therapeutic, because a sense of control and self-efficacy is linked to better pain outcomes. None of this means going it alone; it means working in partnership with the care team, who provide expertise, treatment, and support while the person leads the daily work.

Even with good management, chronic pain often comes with flares — periods when pain temporarily worsens, sometimes for an obvious reason (overdoing it, stress, poor sleep, illness, weather) and sometimes for no clear reason. Flares are distressing but usually temporary and not a sign that damage is occurring or that all progress is lost. Having a flare plan agreed with the care team helps: it might include gentle continuation of movement within limits (rather than complete rest), relaxation and breathing techniques, using agreed coping strategies and any short-term measures the care team has advised, reducing nonessential demands, and reminding oneself that the flare will pass. Reacting to every flare with fear, prolonged rest, or escalating medication can deepen the boom-and-bust cycle and increase disability over time, whereas a calm, practiced response limits the disruption. Tracking flares can also reveal triggers to manage. Knowing in advance how to respond turns flares from frightening setbacks into manageable bumps, preserving momentum toward the person's goals.

Chronic pain affects far more than the body. It can wear down mood, fuel anxiety and frustration, disturb sleep, strain relationships, and lead to isolation as activities and social contact shrink — and these effects loop back to worsen the pain itself. Recognizing this, good care treats emotional wellbeing as part of pain management, not a separate issue. Helpful steps include staying connected to people, keeping up valued activities in adapted forms, managing stress, maintaining routines, and seeking support early when mood or anxiety becomes a struggle. Depression and anxiety are common with chronic pain and are very treatable; getting help for them often improves pain and function as well. Peer support — connecting with others who understand — can reduce isolation and offer practical wisdom. There should be no shame in seeking counseling, joining a support group, or asking the care team about mental-health resources; doing so is a constructive, proactive part of managing a hard condition. If feelings of hopelessness or thoughts of self-harm arise, it is important to reach out for help urgently.

Chronic pain reaches into work, family, and everyday tasks, but with adjustments many people stay meaningfully engaged — and staying engaged generally helps pain rather than harming it. At work, reasonable adjustments (modified duties, flexible hours, ergonomic changes, breaks for movement) can make staying in or returning to work possible, which benefits finances, identity, and wellbeing; prolonged time off, by contrast, can worsen outcomes. At home, planning and pacing tasks, using aids, and sharing the load help. Relationships can be strained when pain is invisible and others struggle to understand; honest communication about needs and limits, and including loved ones in understanding the condition, can ease this. Loved ones can support best by encouraging activity and independence rather than over-protecting, which (though well-meant) can reinforce disability. Occupational therapists, employers' support schemes, and pain-management programs offer practical help. The recurring theme is adaptation rather than withdrawal: finding modified ways to keep doing what matters protects both quality of life and, indirectly, the pain itself.

Safe handling of pain medicines is an important and often overlooked part of self-care, especially with opioids and sedatives. Medicines should be stored securely — ideally locked away — and out of reach of children, teens, visitors, and anyone at risk, because accidental ingestion (particularly by children) and misuse of medicines kept in the home are real dangers; even a single opioid dose can be life-threatening to a child. Pain medicines should never be shared with others, since a dose safe for one person can seriously harm or kill another, and the prescriber tailors them to the individual. Unused or expired opioids should be disposed of promptly and safely, for example through drug take-back programs or pharmacy disposal options, rather than left in a cabinet where they can be misused or cause accidental poisoning. For those prescribed opioids, keeping naloxone available and ensuring household members know how to use it adds a vital safety layer. A pharmacist can advise on secure storage, safe disposal in your area, and naloxone, making the home environment safer for everyone in it.

Among the most significant consequences of chronic pain are its effects on mental health. Living with ongoing pain, disrupted sleep, lost activities, and uncertainty markedly raises the risk of depression and anxiety, which are far more common in people with chronic pain than in the general population. This is a two-way street — pain worsens mood and low mood worsens pain — so the two can spiral together if not addressed. In more severe cases, chronic pain and accompanying depression can lead to hopelessness and thoughts of self-harm or suicide, a recognized and serious risk that warrants attention. None of this reflects weakness; it is a predictable consequence of a hard, persistent condition and the nervous-system links between pain and mood. The practical message is that monitoring and treating mental health is an integral part of pain care, that effective help exists, and that anyone experiencing severe low mood, hopelessness, or thoughts of self-harm should reach out urgently to their care team, a crisis line, or emergency services.

Disturbed sleep is one of the most common and burdensome consequences of chronic pain. Pain makes it hard to fall asleep, causes frequent waking, and reduces deep, restorative sleep, while some pain conditions (and some medicines) further fragment it. The result is daytime fatigue, low energy, and difficulty concentrating — sometimes called 'brain fog' — that affect work, mood, relationships, and the ability to follow a pain-management plan. Crucially, poor sleep also turns up pain sensitivity, so the sleep problem feeds back into the pain, creating a self-reinforcing cycle that can become a major complication. Because of this, sleep problems are not just an unfortunate side effect to endure; they are a target for treatment, addressed through sleep habits, cognitive behavioral therapy for insomnia, treating sleep disorders like sleep apnea, and managing pain at night. Breaking the pain-sleep cycle frequently improves not only rest and energy but the pain and mood as well, which is why sleep is given real attention in comprehensive pain care.

A common and damaging consequence of chronic pain is physical deconditioning. When pain leads a person to avoid movement and rest excessively — an understandable response — muscles weaken, joints stiffen, balance and cardiovascular fitness decline, and weight may increase. This deconditioning makes activity harder and more painful, which encourages more avoidance, producing a downward spiral of rising disability. Fear of movement (kinesiophobia) and the belief that hurting means harming reinforce the cycle. Chronic pain is, indeed, one of the leading causes of long-term disability and activity limitation worldwide, with chronic low back pain a major contributor. The encouraging flip side is that much of this is preventable and even reversible: graded activity, exercise, and physical therapy rebuild strength and capacity, and pain education that 'hurt does not equal harm' helps overcome the fear driving avoidance. Recognizing deconditioning as a complication — rather than an inevitable part of the pain — reframes staying active as protective, and is a central reason movement sits at the heart of pain management.

Beyond the body, chronic pain takes a heavy social and economic toll. As pain limits activities, people may withdraw from hobbies, social events, and relationships, leading to isolation and loneliness that worsen mood and, in turn, pain. Relationships with partners, family, and friends can become strained, especially when the pain is invisible and hard for others to understand, and roles within a household may shift. Work is often affected: chronic pain is a leading reason for reduced productivity, absence, and job loss, which brings financial stress that adds another layer of difficulty. These social and economic impacts are not peripheral — they are part of the burden of the condition and feed back into the biopsychosocial cycle that sustains pain. They are also reasons that comprehensive care looks beyond the clinic: occupational support and workplace adjustments, help maintaining social connection, peer support, and addressing financial and practical stressors all matter. Treating chronic pain well means helping a person keep, or rebuild, a connected and meaningful life, not just lowering a pain score.

Some of the most serious complications in chronic pain arise not from the pain itself but from its treatment, particularly long-term opioid use. Over time the body develops tolerance (needing more for the same effect) and physical dependence (withdrawal symptoms if the drug is stopped abruptly), which are expected pharmacological effects rather than addiction. In a minority of people, however, use progresses to opioid use disorder — compulsive use despite harm — which is a treatable medical condition, not a moral failing. The gravest risk is overdose: opioids can fatally slow breathing, especially at higher doses, after a loss of tolerance, or when combined with benzodiazepines, alcohol, or other sedatives. Other long-term effects include persistent constipation, hormonal changes, increased fall risk, and, paradoxically, heightened pain sensitivity in some people (opioid-induced hyperalgesia). These harms are why opioids are used cautiously and monitored, why naloxone is offered to those at risk, and why anyone struggling with opioids deserves support and access to effective treatment for opioid use disorder rather than blame.

Opioids are not the only pain treatments with potential long-term harms; other medicines carry their own cumulative risks that matter with ongoing use. Regular NSAIDs (such as ibuprofen, naproxen, diclofenac) can cause stomach ulcers and bleeding, kidney injury, fluid retention, raised blood pressure, and cardiovascular effects, with risk rising over time and in older people or those with kidney, heart, or stomach conditions. Acetaminophen is generally safer but can damage the liver if the daily limit is exceeded, a danger compounded by hidden acetaminophen in combination products and by heavy alcohol use. The nerve-pain medicines — gabapentin, pregabalin, duloxetine, and tricyclics — can cause drowsiness, dizziness, weight changes, dry mouth, and other effects, and gabapentinoids can dangerously add to the sedation and breathing suppression of opioids and other depressants. These risks do not mean the medicines should be avoided, but they explain why long-term pain treatment is reviewed periodically, why the lowest effective doses are favored, and why a pharmacist or clinician should oversee the combined regimen, especially when several medicines and conditions overlap.

People managing chronic pain often take several medicines — sometimes an opioid, a nerve-pain drug, an anti-inflammatory, a sleep or anxiety medicine, and supplements — and many of these interact. Some combinations add up dangerously (especially anything that slows breathing on top of opioids), some raise the risk of serotonin syndrome, and some compound stomach, kidney, or liver risks. The entries here explain the best-known interactions so a person can recognize and ask about them, but they are not a substitute for an authoritative check. Whether a given combination is a problem for a particular person depends on their other conditions, kidney and liver function, doses, and timing — exactly the judgment a pharmacist or prescriber is trained to make. Practical habits that genuinely reduce risk: keep one up-to-date list of every prescription, over-the-counter product, vitamin, and herbal supplement; show it at every appointment and to the pharmacist with each new prescription; use one pharmacy where possible so interactions are screened automatically; and specifically ask 'does this interact with my pain medicines?' before starting anything new — including alcohol. Never treat any entry here as a definitive ruling.

The most dangerous interaction in chronic-pain treatment is opioids combined with other central-nervous-system depressants. Benzodiazepines (diazepam, alprazolam, lorazepam, and others, used for anxiety or sleep), alcohol, 'Z-drug' sleep medicines, sedating muscle relaxants, and sedating antihistamines all suppress breathing, and their effects stack with opioids to cause profound respiratory depression that can be fatal. The opioid–benzodiazepine combination in particular contributes to a large share of opioid-overdose deaths, which is why the CDC guideline advises avoiding co-prescribing them whenever possible and why prescribers and pharmacists scrutinize these combinations. This does not mean a person taking both has done anything wrong, but it is a high-risk situation that calls for review — and, where the combination must continue, for extra caution and access to naloxone. Critically, several of these drugs (especially benzodiazepines and some others) cannot be stopped abruptly without risk, so changes must be made by the prescriber, never alone. Anyone on opioids should disclose all sedatives, sleep aids, and alcohol use so the combined risk can be managed.

Gabapentin and pregabalin (the 'gabapentinoids') are widely used for neuropathic pain and are often prescribed alongside opioids, but the combination deserves caution. On their own these drugs can cause drowsiness and dizziness; combined with opioids, they can add to sedation and, importantly, to respiratory depression, and research has linked the co-use of gabapentinoids and opioids to an increased risk of opioid-related overdose death compared with opioids alone. Regulators have issued warnings about the risk of serious breathing problems when gabapentinoids are taken with opioids or other CNS depressants, particularly in older adults and people with reduced lung function. This does not make the combination forbidden — it is sometimes clinically appropriate as part of reducing opioid doses — but it is a reason for careful dosing, monitoring for excess sedation, and awareness of the additive overdose risk, including ensuring naloxone is available where relevant. As always, the balance is a decision for the prescriber, and neither drug should be started, stopped, or changed without medical guidance, since gabapentinoids can also cause withdrawal if stopped suddenly.

Several pain-related medicines increase serotonin activity, and combining them can, uncommonly, cause serotonin syndrome — a reaction ranging from mild to life-threatening. Culprits in pain care include the SNRI duloxetine, tramadol, and tapentadol, which can interact with each other and with SSRIs/SNRI antidepressants, tricyclics, migraine 'triptans,' the supplement St. John's wort, certain other opioids (such as fentanyl and methadone), some anti-nausea drugs, and MAO inhibitors. Symptoms can develop within hours of a new or increased serotonergic drug and include agitation or confusion, a fast heart rate, high blood pressure, dilated pupils, twitching or muscle rigidity, heavy sweating, shivering, diarrhea, and, in severe cases, high fever — a medical emergency. Because so many pain and mood medicines act on serotonin, this is a real-world interaction worth knowing, especially as tramadol is sometimes assumed to be a 'mild' painkiller. The risk is manageable: prescribers and pharmacists check for serotonergic combinations and watch dosing. Anyone starting a new medicine who develops these symptoms should seek urgent medical advice, and all serotonergic drugs and supplements should be on the medication list.

NSAIDs (ibuprofen, naproxen, diclofenac, and others) are effective for inflammatory pain but interact with several common medicines. They raise bleeding risk when combined with anticoagulants and antiplatelet drugs (such as warfarin, direct oral anticoagulants, and aspirin) and add to stomach-ulcer risk, especially with steroids or in people with prior ulcers. They can blunt the effect of blood-pressure medicines and, importantly, stress the kidneys — a particular concern in the so-called 'triple whammy,' where an NSAID is combined with a diuretic ('water pill') and an ACE inhibitor or ARB, a trio that can cause acute kidney injury, especially during dehydration or illness. NSAIDs can also interact with lithium, methotrexate, and some diabetes medicines, and taking two NSAIDs together multiplies risk without added benefit. Older adults and people with heart, kidney, or liver disease are most vulnerable. None of this makes NSAIDs off-limits, but it is why even over-the-counter use should be checked against the person's other medicines and conditions. A pharmacist can quickly flag these combinations and suggest safer options or protective measures.

Acetaminophen (paracetamol) is one of the most widely used pain relievers and is generally safe at recommended amounts, but exceeding the daily limit can cause severe, sometimes fatal, liver injury. A key real-world hazard is accidental double-dosing: acetaminophen is hidden in many combination products — cold and flu remedies, some prescription opioid–acetaminophen painkillers, and sleep aids — so a person can unknowingly take it from several sources at once and exceed the safe total. Regular heavy alcohol use increases the liver's vulnerability, and people with liver disease may need a lower limit. This makes acetaminophen an 'interaction' worth understanding even though it is sold over the counter: the interaction is with other acetaminophen-containing products and with alcohol. The protective steps are to read labels for acetaminophen (or paracetamol) content, avoid taking multiple products that contain it, stay within the recommended daily maximum, and check with a pharmacist if combining medicines or if liver disease or significant alcohol use is a factor. Suspected acetaminophen overdose is a medical emergency even if the person feels well, because liver damage can be delayed.

Interactions are not limited to prescriptions. The herbal antidepressant St. John's wort both adds to serotonin (raising serotonin-syndrome risk with duloxetine, tramadol, and others) and speeds the breakdown of many medicines, lowering their levels. Sedating supplements such as valerian, kava, and high-dose melatonin can add to the drowsiness of opioids, gabapentinoids, and sleep aids, while kava has been linked to liver harm. Some supplements affect bleeding (for example, high-dose fish oil, ginkgo, garlic), which matters alongside NSAIDs or blood thinners. A particular hazard is that some 'natural' pain or arthritis products have been found adulterated with hidden pharmaceuticals — including NSAIDs, steroids, or sedatives — creating unexpected interactions and risks. Because supplements and OTC medicines are easy to start without a prescription screen, they are exactly where interactions get missed. The same rule applies as for prescriptions: keep them on the medication list, and run anything new past a pharmacist who can check it against the full regimen and the person's conditions before it is started.

Chronic pain seldom exists by itself. It frequently co-occurs with mental-health conditions (especially depression and anxiety), sleep disorders, substance use problems, and a range of physical conditions, and these overlaps are not coincidental — they share biology and they feed one another. The interactions run in both directions: chronic pain raises the risk of depression, insomnia, and other conditions, and those conditions in turn intensify pain and make it harder to manage. This compounding, and sometimes conflicting management considerations, is why comprehensive pain care looks beyond the pain to screen for and treat what accompanies it, and why coordination across the care team matters so much. Treating an accompanying condition — lifting depression, restoring sleep, addressing a substance use disorder — often improves the pain itself, while ignoring it undermines pain treatment. The entries here map the conditions that most commonly travel with chronic pain and how they interact, as grounding for thinking about more than one condition at once.

Depression and anxiety are among the most common companions of chronic pain, occurring far more often than in the general population. The link is bidirectional and biological: persistent pain, lost activities, poor sleep, and uncertainty drive low mood and worry, while depression and anxiety amplify pain perception, sap motivation for self-care, and make coping harder — so the conditions reinforce one another in a cycle. This compounding has direct treatment implications. Some medicines used for pain (notably the SNRI duloxetine and tricyclic antidepressants) can help both neuropathic/nociplastic pain and mood, an example of one treatment serving two conditions, though serotonergic combinations must be checked for interactions. Psychological therapies such as CBT and ACT likewise benefit pain and mood together. Because untreated depression and anxiety worsen pain outcomes and, in severe cases, carry a risk of self-harm, screening for and treating them is a core part of pain care rather than an optional add-on. Coordinating mental-health and pain treatment — ideally in an integrated way — typically improves both.

Sleep disorders, especially insomnia, are extremely common in chronic pain and form one side of a tightly linked triad with pain and mood. Pain disrupts sleep, and poor sleep lowers the pain threshold and worsens mood the next day, so the three problems compound and can entrench one another. Obstructive sleep apnea also co-occurs with chronic pain and is particularly important to identify in anyone taking opioids or sedatives, because these drugs further suppress breathing during sleep and raise overdose risk in people with sleep-disordered breathing. The compounding nature of the pain–sleep relationship means that addressing sleep is a genuine pain treatment: cognitive behavioral therapy for insomnia (CBT-I) is effective and avoids medication interactions, sleep-disorder treatment helps, and good sleep habits support both pain and mood. Caution is needed with sleep medicines, since several (benzodiazepines, Z-drugs, sedating antihistamines) add dangerously to opioid sedation. Because of these interlocking effects and safety considerations, sleep is assessed and managed as an integral part of multi-condition pain care.

A central concept in chronic-pain care is the bidirectional, three-way relationship between pain, mood, and sleep. Pain disturbs sleep and lowers mood; poor sleep heightens pain sensitivity and worsens mood; and depression or anxiety amplify pain and degrade sleep. Each pairing runs in both directions, so the three can spiral downward together — but this also means there are several entry points for improvement, because gains in one area tend to ripple to the others. Treating depression can improve sleep and reduce pain; restoring sleep can lift mood and ease pain; reducing pain can improve both sleep and mood. This is why effective care rarely targets pain in isolation and instead addresses the whole triad, often with overlapping treatments: exercise, CBT or ACT, sleep interventions, and, where appropriate, medicines that help more than one problem. Understanding the loop also helps people make sense of bad stretches — a poor night or a low mood can flare the pain — and reframes managing sleep and mood as powerful, legitimate pain-management strategies rather than side concerns.

Substance use disorders, including opioid and alcohol use disorder, can co-occur with chronic pain, and each complicates the other. Long-term opioid treatment can, in a minority of people, lead to opioid use disorder, and people with a history of substance use disorder are at higher risk of harm from opioids — which is why guidelines emphasize assessing this risk, favoring non-opioid treatments, and offering naloxone, rather than simply avoiding or withholding pain care. Alcohol is its own concern: it worsens sleep and mood, interacts dangerously with opioids and sedatives, and stresses the liver alongside acetaminophen. The compounding works both ways — untreated pain can drive substance use as people seek relief, and substance use worsens pain, mood, and function. The key principles are coordination and compassion: pain and substance use disorder are both real medical conditions that deserve treatment, effective treatments for opioid use disorder exist, and people who are struggling need support and access to care, not blame or abandonment. Managing this overlap well requires the care team, often including addiction-medicine expertise, to balance pain relief with safety.

Chronic pain overlaps with many physical conditions, in both directions. Some directly cause pain — osteoarthritis and inflammatory arthritis, diabetes (through neuropathy), and others — so treating the underlying disease is part of pain care. Others share risk factors or complicate treatment: heart, kidney, liver, and stomach conditions all narrow the safe options for common pain medicines (NSAIDs strain the kidneys and heart and can cause ulcers; acetaminophen stresses the liver; many drugs are cleared by the kidneys), and obesity both worsens joint pain and accompanies several of these conditions. The result is often polypharmacy — several conditions meaning several medicines — which raises the risk of drug interactions (see the Key Drug Interactions section), cumulative side effects, and a heavy self-care burden. Different conditions can also pull treatment in different directions, where the best choice for the pain must be balanced against its effect on another organ or disease. Managing this well depends on coordination: a care team that sees the whole picture, periodic medication review and reconciliation (a role pharmacists are especially suited to), and simplifying regimens where possible. The combined plan — not any single condition's ideal in isolation — is what good multi-condition care optimizes.

One of the most active frontiers in pain medicine is the search for analgesics that relieve pain without the addiction and overdose risks of opioids. A landmark example is suzetrigine (brand name Journavx), which the U.S. FDA approved in early 2025 — the first new class of pain medicine in decades. It works by blocking a sodium channel called Nav1.8 that helps transmit pain signals in peripheral nerves, before they reach the brain, so unlike opioids it is not expected to be addictive. Its initial approval is for moderate-to-severe acute (short-term) pain in adults; its role in chronic pain is still being studied and is not established. Other non-opioid mechanisms — including additional sodium-channel blockers, nerve growth factor (NGF) inhibitors, and novel targets — are in various stages of research, with mixed results so far (some NGF inhibitors, for instance, showed pain benefit but raised joint-safety concerns in trials). The honest picture is encouraging but early: a genuinely new approved non-opioid is a real advance, but proving lasting benefit and safety across chronic-pain conditions takes time, and most candidates remain investigational.

The NIH Helping to End Addiction Long-term (HEAL) Initiative is a major, sustained federal research program launched to tackle two linked problems: the need for more effective, non-addictive pain treatments and the opioid and overdose crisis. It funds a broad portfolio — from basic science on how pain becomes chronic, to discovery of new non-opioid drug targets, to clinical trials of devices, behavioral therapies, and care models, to better approaches for preventing and treating opioid use disorder. The initiative reflects a recognition that progress requires work across many fronts at once, and it is one reason several of the emerging approaches in this section exist. For people living with pain, HEAL is not a treatment but context: it signals serious, well-funded effort to expand the options beyond opioids and to understand chronic pain more deeply. As with all research, results emerge gradually and not every funded avenue will succeed, but the scale of the effort is a realistic source of hope for better tools over time. Reputable updates on its progress are published by NIH.

Neuromodulation — using electrical or magnetic signals to alter pain processing — is an active research area building on established tools like spinal cord stimulation. Newer directions include refined stimulation patterns (such as high-frequency or 'closed-loop' systems that adjust stimulation in real time), dorsal root ganglion stimulation for focal pain, and peripheral nerve stimulation for specific nerves. Non-invasive brain-targeted approaches, such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS), are being studied for certain chronic-pain conditions, with mixed and generally preliminary evidence. NINDS notes that less-damaging stimulation techniques have largely replaced older nerve-destroying surgeries for many situations. The honest status varies by method: spinal cord stimulation is an established option for carefully selected people, while many of the newer or brain-targeted techniques remain investigational, with benefits that are uncertain or modest and that need confirmation in larger trials. These approaches are specialized, do not cure the underlying problem, and are pursued within expert pain centers as part of a broader plan rather than as stand-alone fixes.

Regenerative injections — platelet-rich plasma (PRP) and various cell-based ('stem cell') therapies — are widely promoted for osteoarthritis, tendon problems, and back pain, but the evidence does not yet support them as proven treatments. For PRP, study results are mixed and inconsistent across conditions, and it is generally considered investigational. For stem-cell-based injections, rigorous evidence of benefit for most pain conditions is lacking, and regulators have raised serious concerns: the FDA has warned that many products marketed directly to patients are unapproved and that unproven stem-cell 'clinics' have caused harm, including serious infections and injuries, while charging large out-of-pocket sums for unvalidated procedures. This is a clear case where honest labeling matters: legitimate research into regenerative approaches continues, but the marketing has run far ahead of the science. People considering these treatments should be skeptical of clinics promising cures, ask whether the therapy is FDA-approved or offered within a registered clinical trial, and discuss it with their own care team before paying for or undergoing any such procedure.

Digital tools are an emerging frontier in pain management. Virtual reality (VR) can immerse a person in calming or engaging environments and deliver guided relaxation, education, and behavioral skills; in 2021 the FDA authorized a prescription VR system (EaseVRx, later RelieVRx) as an adjunct treatment for chronic low back pain in adults, based on a trial showing reduced pain compared with a control program. App-based 'digital therapeutics' deliver CBT, ACT, pain education, and self-management coaching through a phone or computer, expanding access to evidence-based psychological approaches that are otherwise hard to obtain. The honest evidence picture is early and developing: some programs show promising results and one VR product has regulatory authorization, but the field is new, products vary widely in quality and evidence, and long-term benefits are still being established. These tools are generally low-risk and best viewed as adjuncts that extend proven approaches (especially pain psychology and self-management) rather than replacements for comprehensive care. As with any treatment, it is worth discussing whether a particular digital tool is evidence-based and appropriate with the care team.

Complementary and integrative approaches have a more encouraging evidence base in chronic pain than in many other conditions: NCCIH's reviews find that several mind-body and physical approaches — including acupuncture, mindfulness/meditation, yoga, tai chi, massage, and spinal manipulation — can offer modest but real benefits for certain pain conditions, fitting naturally into the multimodal model of pain care. A few principles guide their use. They are best seen as complements that extend an active, comprehensive plan, not replacements for medical evaluation and treatment, and they should never delay assessment of a potentially serious problem. 'Natural' does not mean risk-free: manual therapies have some risks, herbal supplements can interact with medicines, and quality and training vary. Evidence differs by approach and by condition, so what helps low-back pain may not help neuropathy. The consistent advice is to discuss any complementary approach with the care team, choose qualified practitioners, and judge each on its evidence and safety for the specific situation. Used wisely, these approaches can add helpful tools — especially for self-management and the mind-body side of pain — within a coordinated plan.

Acupuncture involves stimulating specific body points, usually with thin needles. It is among the more studied complementary approaches for pain, and NCCIH summarizes the research as suggesting that acupuncture may help with several often-chronic pains — including low-back and neck pain, osteoarthritis/knee pain, and carpal tunnel syndrome — and may reduce the frequency of tension headaches and help prevent migraines. The evidence is mixed in important ways: some trials find 'real' and simulated ('sham') acupuncture similarly effective, suggesting part of the benefit may be a placebo or contextual effect, but for several pain conditions the overall body of evidence is encouraging enough that acupuncture is offered as a reasonable option to try. It is generally safe when performed by a qualified, licensed practitioner using sterile single-use needles; serious side effects are rare, while soreness and minor bleeding or bruising can occur. As with all these approaches, acupuncture is best used within a broader plan and should not replace evaluation of a serious problem. Checking a practitioner's training and licensing, and telling the care team, are sensible steps.

Mindfulness meditation and mindfulness-based stress reduction (MBSR) train nonjudgmental, present-moment awareness, including of pain, in a way that can change pain processing and reduce the stress and emotional reactivity that amplify pain. NCCIH-reviewed evidence indicates that mindfulness-based programs can produce modest reductions in chronic-pain intensity and improvements in depression symptoms and quality of life for some people, across conditions such as chronic low-back pain, fibromyalgia, and headache. While the size of the benefit varies and the research is still maturing, mindfulness stands out as low-risk, increasingly accessible (through classes, programs, and apps), and aligned with the broader emphasis on self-management and the mind-body side of pain. It overlaps with the psychological-therapies section because the same skills appear there; the point of including it here is that meditation is also a self-directed practice many people adopt on their own. Benefits build with regular practice, and it works best as part of a comprehensive plan. A small minority of people experience unpleasant effects, so those with significant mental-health conditions may want guidance from a qualified instructor or clinician.

Yoga blends physical postures, breathing techniques, and meditation, making it a natural fit for chronic pain because it works on the body and the mind-body stress response at once. NCCIH notes that a substantial body of research on low-back pain suggests yoga may provide benefit, with smaller amounts of evidence indicating it may help neck pain, headaches, and knee osteoarthritis pain, as well as supporting sleep, mood, balance, and stress management — all relevant to living with pain. The benefits are generally modest and comparable to other forms of exercise, which is consistent with the central role of movement in pain care. Yoga is generally safe for most people when practiced appropriately, but injuries can happen, so working with a qualified instructor, choosing a style and intensity suited to one's condition, modifying poses as needed, and avoiding pushing into pain reduce the risk. People with specific conditions (such as certain spine problems, glaucoma, or pregnancy) should check with their care team about precautions. As an enjoyable, sustainable form of activity that many people will stick with, yoga can be a valuable part of a multimodal plan.

Tai chi and the related practice qigong combine slow, flowing movements with controlled breathing and focused attention, offering a gentle, low-impact form of exercise with a mind-body component. NCCIH summarizes encouraging evidence that tai chi may help relieve symptoms of fibromyalgia and may improve pain and physical function in osteoarthritis (including of the knee), and there is good evidence that tai chi reduces the risk of falls in older adults — valuable because pain, deconditioning, and some medicines raise fall risk. Its gentle, adaptable nature makes it accessible to many people who find more vigorous exercise difficult, including older adults and those with significant limitations, which helps people stay active — a core goal of pain management. Tai chi and qigong appear safe, with serious injury unlikely, though minor aches can occur, especially when starting. Because instruction is not formally regulated, choosing an experienced instructor and starting gently are wise. As a sustainable, enjoyable practice that builds strength, balance, and calm, tai chi fits well within a comprehensive, movement-centered approach to chronic pain.

Massage therapy involves manipulating the body's soft tissues and is widely used for pain and relaxation. NCCIH's assessment is that massage may help relieve several kinds of pain, but in most cases the evidence is not strong and the relief tends to be short-term; for example, several studies of massage for knee osteoarthritis found short-term pain relief, and it may help low-back and neck pain and ease anxiety and depression in conditions like fibromyalgia. So massage is reasonably viewed as a helpful adjunct that can provide temporary comfort, reduce muscle tension, and support relaxation and wellbeing, rather than a stand-alone cure. It appears to have few risks when performed by a trained practitioner, though people with certain health conditions (such as bleeding disorders, blood clots, or some skin or bone conditions) and pregnant people should check with their care team first and may need to avoid certain techniques or areas. Choosing a qualified, licensed massage therapist and communicating about comfort and any medical conditions helps keep it safe. As part of a multimodal plan, massage can contribute to the relaxation and self-care side of managing chronic pain.

Spinal manipulation — a controlled thrust applied to a spinal joint, performed by chiropractors, osteopathic physicians, and some physical therapists — is commonly used for back and neck pain. NCCIH notes moderate-quality evidence that spinal manipulation can produce modest improvements in pain and function for low-back pain, with benefits broadly similar to other conservative treatments such as exercise or NSAIDs; evidence for neck pain and certain headaches is more limited. Mild, temporary side effects like local soreness or a short-term increase in pain are common after treatment. Serious complications are rare, but neck (cervical) manipulation has been associated, very uncommonly, with serious events including stroke from injury to arteries in the neck, which is why discussing risks and choosing a qualified, licensed practitioner is important — particularly before any forceful neck manipulation. People with certain conditions (such as osteoporosis, inflammatory arthritis affecting the spine, or signs of nerve compression) should avoid manipulation or seek medical clearance first. Within a broader plan, and with appropriate caution, spinal manipulation is one reasonable option some people find helpful for mechanical back pain.